IDRA-21 (CAS 22503-72-6) — laboratory reagent 1000 mg, purity ≥ 99%
⬇ Pobierz etykietę

69,11 zł

IDRA-21 is 20 to 30 times more potent than Aniracetam. The issue supports cognitive processes also has its dark side…. in high doses IDRA-21 can exhibit neurotoxic effects!

📄 Pobierz Karte Charakterystyki (PDF) v1 · 28.04.2026 · REACH 2020/878

Out of stock

Tags:
Legal / safety notice: All products offered are pure chemical reagents intended solely for laboratory and research use. They are not for human or animal consumption, are not medicinal products, dietary supplements or medical devices, and are not intended for testing or diagnostics on humans or animals. The scientific data presented refers to the active substance and is provided for informational and educational purposes only — it does not constitute a recommendation for use.
🧬 Wizualizator molekuły 3D
Ładowanie molekuły...
Model 3D Idra 21, CAS 22503-72-6, wzór sumaryczny C8H9ClN2O2S, masa molowa 232.69 g/mol
📊 Dane fizykochemiczne — CAS 22503-72-6MolGod_PROPHUB_MAIN
MolGod_PROPCARD_PR1
📊 Physical & Chemical Properties SEO+

Quick Reference

Formula: C8H9ClN2O2S
MW: 232.69 g/mol
CAS: 22503-72-6

Detailed Properties

Property Value Unit Conditions Source
🔬 Advanced Properties

Chemical Identifiers

SMILES: CC1NC2=C(C=C(C=C2)Cl)S(=O)(=O)N1

Data sources: PubChem, NIST Chemistry WebBook, CRC Handbook of Chemistry and Physics (103rd ed.)

Last updated: 2026-04-28

Chemical Overview: Idra 21MolGod_OVERVIEW_1
Molecular formulaC8H9ClN2O2S
Molecular weight232.69 g/mol
LogP (lipophilicity)1.5
IUPAC name7-chloro-3-methyl-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine 1,1-dioxide
SMILESCC1NC2=C(C=C(C=C2)Cl)S(=O)(=O)N1
InChIKeyVZRNTCHTJRLTMU-UHFFFAOYSA-N

Synonyms: 22503-72-6 · Idra-21 · idra 21 · 689UW7PT68 · IDRA21

Data sources: PubChem (NLM/NIH)
Last updated: 2026-07-04

Brak wpisow dla tego CAS w sprawdzonych wykazach ograniczen (lista kandydacka SVHC, REACH Zalacznik XVII; zbiory niepelne - nie jest to potwierdzenie zgodnosci). Klasyfikacja CLP i status transportowy (ADR): patrz sekcja GHS oraz karta charakterystyki (SDS).